WJA
NVS icon

Williams Jones & Associates’s Novartis NVS Stock Holding History

Williams Jones & Associates’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$594K Sell
6,501
-1,459
-18% -$123K 0.01% 250
2019
Q1 		$686K Sell
7,960
-274
-3% -$22K 0.02% 236
2018
Q4 		$633K Buy
8,234
+320
+4% +$24.9K 0.02% 230
2018
Q3 		$611K Buy
7,914
+69
+0.9% +$5.1K 0.01% 263
2018
Q2 		$531K Buy
7,845
+558
+8% +$38.5K 0.01% 283
2018
Q1 		$528K Sell
7,287
-187
-3% -$14.2K 0.01% 282
2017
Q4 		$562K Buy
7,474
+187
+3% +$14.1K 0.01% 286
2017
Q3 		$561K Buy
7,287
+111
+2% +$8.38K 0.01% 276
2017
Q2 		$537K Hold
7,176
– – 0.01% 273
2017
Q1 		$478K Buy
7,176
+558
+8% +$37.2K 0.01% 278
2016
Q4 		$432K Sell
6,618
-1,875
-22% -$122K 0.01% 287
2016
Q3 		$601K Hold
8,493
– – 0.02% 253
2016
Q2 		$628K Buy
8,493
+1,875
+28% +$130K 0.02% 235
2016
Q1 		$430K Sell
6,618
-1,267
-16% -$86.2K 0.02% 222
2015
Q4 		$608K Sell
7,885
-111
-1% -$8.82K 0.03% 209
2015
Q3 		$659K Hold
7,996
– – 0.03% 213
2015
Q2 		$705K Sell
7,996
-112
-1% -$10.3K 0.03% 223
2015
Q1 		$716K Hold
8,108
– – 0.03% 232
2014
Q4 		$673K Buy
8,108
+2,902
+56% +$241K 0.03% 233
2014
Q3 		$439K Sell
5,206
-999
-16% -$80.8K 0.02% 226
2014
Q2 		$503K Sell
6,205
-14,910
-71% -$1.17M 0.02% 214
2014
Q1 		$1.61M Buy
21,115
+14,910
+240% +$1.09M 0.03% 204
2013
Q4 		$447K Buy
6,205
+592
+11% +$41.2K 0.02% 196
2013
Q3 		$386K Sell
5,613
-5,246
-48% -$347K 0.02% 208
2013
Q2 		$688K Buy
+10,859
New +$707K 0.03% 194

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Williams Jones & Associates's NVS Position: Q2 2019 in Review

Williams Jones & Associates reduced its Novartis (NVS) stake by 18% in Q2 2019, selling an estimated $123K and leaving 6,501 shares worth $594K. The position accounts for 0.01% of the portfolio, ranked #250.

Williams Jones & Associates first reported a position in NVS in Q2 2013 and has held it in 25 quarters since. The position peaked at $1.61M in Q1 2014. 1,094 funds tracked by Wall St. Rank hold NVS as of Q2 2019.

  • Williams Jones & Associates held 6,501 shares of Novartis worth $594K as of Q2 2019.
  • Williams Jones & Associates sold 1,459 Novartis shares in Q2 2019, an estimated $123K.
  • Novartis made up 0.01% of Williams Jones & Associates's portfolio in Q2 2019, its #250 holding.
  • Williams Jones & Associates first reported a position in Novartis in Q2 2013 and has held it in 25 quarters since.
  • Williams Jones & Associates's Novartis position peaked at $1.61M in Q1 2014.
  • 1,094 funds tracked by Wall St. Rank held Novartis as of Q2 2019.

Based on Williams Jones & Associates's 13F filing for Q2 2019, filed 14 Aug 2019.